|
1.Takahashi C, Sheng ZQ, Horan TP, et al. Regulation of matrix metalloproteinase-9 and inhibition of tumor invasion by the membrane-anchored glycoprotein RECK. Proceedings of the National Academy of Sciences of the United States of America 1998; 95: 13221-6. 2.Oh J, Takahashi R, Kondo S, et al. The membrane-anchored MMP inhibitor RECK is a key regulator of extracellular matrix integrity and angiogenesis. Cell 2001; 107: 789-800. 3.Furumoto K, Arii S, Mori A, et al. RECK gene expression in hepatocellular carcinoma: Correlation with invasion-related clinicopathological factors and its clinical significance. Hepatology 2001; 33: 189-95. 4.Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nature Reviews Cancer 2002; 2: 161-74. 5.Nagase H, Visse R, Murphy G. Structure and function of matrix metalloproteinases and TIMPs. Cardiovascular Research 2006; 69: 562-73. 6.Overall CM, Lopez-Otin C. Strategies for MMP inhibition in cancer: Innovations for the post-trial era. Nature Reviews Cancer 2002; 2: 657-72. 7.Simizu S, Takagi S, Tamura Y, Osada H. RECK-mediated suppression of tumor cell invasion is regulated by glycosylation in human tumor cell lines. Cancer Research 2005; 65: 7455-61. 8.Sasahara RM, Takahashi C, Noda M. Involvement of the Sp1 site in Ras-mediated downregulation of the RECK metastasis suppressor gene. Biochemical and Biophysical Research Communications 1999; 264: 668-75. 9.Sasahara RM, Takahashi C, Sogayar MC, Noda M. Oncogene-mediated downregulation of RECK, a novel transformation suppressor gene. Brazilian Journal of Medical and Biological Research 1999; 32: 891-5. 10.Sasahara RM, Brochado SM, Takahashi C, et al. Transcriptional control of the RECK metastasis/angiogenesis suppressor gene. Cancer Detection and Prevention 2002; 26: 435-43. 11.Liu LT, Chang HC, Chiang LC, Hung WC. Induction of RECK by nonsteroidal anti-inflammatory drugs in lung cancer cells. Oncogene 2002; 21: 8347-50. 12.Liu LT, Chang HC, Chiang LC, Hung WC. Histone deacetylase inhibitor up-regulates RECK to inhibit MMP-2 activation and cancer cell invasion. Cancer Research 2003; 63: 3069-72. 13.Laemmli Uk. Cleavage Of Structural Proteins During Assembly Of Head Of Bacteriophage-T4. Nature 1970; 227: 680-685. 14.Takagi S, Simizu S, Osada H. RECK Negatively Regulates Matrix Metalloproteinase-9 Transcription. Cancer Research 2009; 69: 1502-8. 15.Chu YW, Yang PC, Yang SC, et al. Selection of invasive and metastatic subpopulations from a human lung adenocarcinoma cell line. American Journal of Respiratory Cell and Molecular Biology 1997; 17: 353-60. 16.Rao JS. Molecular mechanisms of glioma invasiveness: The role of proteases. Nature Reviews Cancer 2003; 3: 489-501. 17.Oh J, Seo DW, Diaz T, et al. Tissue inhibitors of metalloproteinase 2 inhibits endothelial cell migration through increased expression of RECK. Cancer Research 2004; 64: 9062-9. 18.Valster A, Tran NL, Nakada M, Berens ME, Chan AY, Symons M. Cell migration and invasion assays. Methods 2005; 37: 208-15. 19.Clark JCM, Thomas DM, Choong PFM, Dass CR. RECK - a newly discovered inhibitor of metastasis with prognostic significance in multiple forms of cancer. Cancer and Metastasis Reviews 2007; 26: 675-83. 20.Chang CK, Hung WC, Chang HC. The Kazal motifs of RECK protein inhibit MMP-9 secretion and activity and reduce metastasis of lung cancer cells in vitro and in vivo. Journal of Cellular and Molecular Medicine 2008; 12: 2781-9. 21.Laskowski, M., Kato, I. Protein inhibitors of proteinases. Annual Review of Biochemistry 1980; 49: 593-626. 22.McCawley LJ, Matrisian LM. Matrix metalloproteinases: multifunctional contributors to tumor progression. Mol Med Today 2000; 6: 149-56.
|